Bevacizumab-associated osteonecrosis of the jaw

Annals of Oncology

Volumn 19, Issue 12, 2008, Pages 2091-2092

  Greuter, Stefan ^a   Schmid, F ^a   Ruhstaller, T ^a   Thuerlimann, B ^a  

^a Kantonsspital St Gallen ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BISPHOSPHONIC ACID DERIVATIVE;

ADULT; BONE NECROSIS; BONE PAIN; BONE SCINTISCANNING; BREAST CANCER; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG INDUCED DISEASE; DRUG RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAW DISEASE; JAW OSTEONECROSIS; JAW RADIOGRAPHY; LETTER; MAXILLA SINUSITIS; ORAL SURGERY; PRIORITY JOURNAL; SURGICAL DRAINAGE; TOOTH EXTRACTION; TOOTH INFECTION; TREATMENT DURATION; TRIGEMINUS NEURALGIA;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DOXORUBICIN; FEMALE; HUMANS; JAW DISEASES; MAXILLARY SINUSITIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OSTEONECROSIS; TOOTH DISEASES;

EID: 56749177288     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn653     Document Type: Letter

References (5)

1. Woo S-B, Hellstein JW, Kalmar JR. Narrative review: Bisphosphonates and osteonecrosis of the jaw. Ann Intern Med 2006; 144: 753-761.
2. Vincenzi B, Santini D, Rocci L, Tonini G. Bisphosphonates: New antiangiogenic molecules in cancer treatment? Ann Oncol 2003; 14: 806-807.
3. Kim KJ, Li B, Houck K et al. The vascular endothelial growth factor proteins: Identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 1992; 7: 53-64.
4. Estilo CL, Fornier M, Farooki A et al. Osteonecrosis of the jaw related to bevacizumab. J Clin Oncol 2008; 26: 4037-4038.
5. Palaia I, Angioli R, Bellati F et al. Distal phalange necrosis: A severe manifestation of palmar plantar erythrodysesthesia. Am J Obstet Gynecol 2006; 195: E1-e2.